Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRavi R. Jhaveri
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection
10.1056/nejmoa1512610 · 2015
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis
10.1016/j.jhep.2017.03.039 · 2017
Responsible inclusion of pregnant individuals in eradicating HCV
10.1002/hep.31825 · 2021
Unresolved referenced work
2023
Viral hepatitis in pregnancy: ACOG clinical practice guideline no. 6
10.1097/aog.0000000000005300 · 2023
Sofosbuvir/velpatasvir pharmacokinetics, safety, and efficacy in pregnant people with hepatitis C virus
10.1093/cid/ciae595 · 2025
Treatment of women with hepatitis C diagnosed in pregnancy: a co-located treatment approach
10.1053/j.gastro.2022.07.017 · 2022
Pharmacokinetics of sofosbuvir and velpatasvir for hepatitis C treatment in pregnancy
10.3390/biomedicines13102462 · 2025
Treatment of hepatitis C during pregnancy-weighing the risks and benefits in contrast to HIV
10.1007/s11904-018-0386-z · 2018
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study
10.1016/s2666-5247(20)30062-8 · 2020
Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of Practice
10.1016/j.ajog.2024.06.028 · 2024
Real-world experience of hepatitis C treatment with glecaprevir/pibrentasvir during pregnancy
10.1093/cid/ciag422 · 2026
Predictive value of sustained virologic response at week 4 in patients with hepatitis C virus infection treated with sofosbuvir/velpatasvir
10.3390/v18020269 · 2026
Temporal trends in hepatitis C virus screening and management in pregnant women and infants between 2014 and 2024 in San Francisco, California [manuscript published online ahead of print 31 March 2026]
10.14309/ajg.0000000000004014 · 2026
CDC recommendations for hepatitis C screening among adults—United States, 2020
10.15585/mmwr.rr6902a1 · 2020
Point-of-care testing for hepatitis C infection: a critical building block for the foundation to achieve elimination
2024
The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination
10.1093/cid/ciad503 · 2024
Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: the ETHOS engage study
10.1093/cid/ciaa571 · 2021
No additional external references are available.